Press releases appear below, filter by date.
In 2016 pharmaceutical companies will disclose details of certain transfers of value made to healthcare professionals (HCPs), other relevant decision makers (ORDMs) and healthcare organisations (HCOs) during 2015 on the ABPI central platform.
Galderma UK Ltd and Merck Serono have each breached Clause 2 of the ABPI Code of Practice and are the subject of advertisements in the medical, pharmaceutical and nursing press.
Gedeon Richter (UK) Ltd has breached the ABPI Code of Practice for the Pharmaceutical Industry and brought discredit upon, and reduced confidence in, the pharmaceutical industry.
Grünenthal Ltd and Vifor Pharma UK Limited have each breached Clause 2 of the ABPI Code of Practice and are the subject of advertisements in the medical, pharmaceutical and nursing press. In addition, Grünenthal has been publicly reprimanded.
All five companies have brought discredit upon, and reduced confidence in, the pharmaceutical industry. In addition Boehringer Ingelheim and Eli Lilly and Company were required to issue a corrective statement.
The ABPI and NHS England have issued a joint letter setting out the ambition to increase consent rates as quickly as possible for publication of payments to individuals on Disclosure UK. The letter, published on 22 December 2017 and signed by ABPI CEO Mike Thompson and NHSE National Director Ian Dodge, is now available on the ABPI website.